Advances in Diagnosis and Therapy of Neuroendocrine Neoplasms

This Special Issue is dedicated to neuroendocrine neoplasms (NENs), a category of malignancy that demonstrates wide clinical heterogeneity, posing major challenges in diagnosis and management. There have been significant advances in the field of NEN genomics, pathology, imaging, and treatment over t...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Format: Online
Jezik:engleski
Izdano: MDPI - Multidisciplinary Digital Publishing Institute 2021
Teme:
Online pristup:ONIX_20210501_9783039437450_99
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
_version_ 1863743299035070464
collection Directory of Open Access Books
description This Special Issue is dedicated to neuroendocrine neoplasms (NENs), a category of malignancy that demonstrates wide clinical heterogeneity, posing major challenges in diagnosis and management. There have been significant advances in the field of NEN genomics, pathology, imaging, and treatment over the past five years. NENs are examples of rare tumours (although their incidence and prevalence are increasing) where international collaborative efforts have allowed the generation of high-level evidence to guide optimal patient-centred care. This issue presents both reviews and original papers to provide comprehensive state-of-the-art understanding of this fascinating disease.
format Online
id doab-20.500.12854ir-68354
institution Directory of Open Access Books
language eng
publishDate 2021
publishDateRange 2021
publishDateSort 2021
publisher MDPI - Multidisciplinary Digital Publishing Institute
publisherStr MDPI - Multidisciplinary Digital Publishing Institute
record_format ojs
spelling doab-20.500.12854ir-683542024-03-31T13:09:51Z Advances in Diagnosis and Therapy of Neuroendocrine Neoplasms Segelov, Eva small bowel neuroendocrine tumours pancreatic neuroendocrine tumours liver metastases midgut meta-analysis neuroendocrine tumors carcinoid heart disease carcinoid syndrome somatostatin analogues metastases multidisciplinary management outcome grading staging neuroendocrine neoplasms chemotherapy temozolomide metronomic treatment second-line NOTCH cancer-driven genes mutational mechanism germline mutations small cell lung carcinoma pancreatic NET small bowel NET medullary thyroid carcinoma malignant castration-resistant prostatic cells quality performance indicators QPIs cancer care neuroendocrine tumour NETs modified Delphi CommNETs pancreatic neuroendocrine neoplasms neuroendocrine tumor long-term functional outcomes pancreatectomy diabetes mellitus pancreatic exocrine insufficiency body mass index parenchyma-sparing surgery neuroendocrine tumours curative surgery resection follow-up guidelines relapse recurrence risk factor mixed non-neuroendocrine neuroendocrine neoplasms MiNENs mixed adeno-neuroendocrine carcinoma MANEC 2017 WHO classification 2019 WHO classification thema EDItEUR::M Medicine and Nursing This Special Issue is dedicated to neuroendocrine neoplasms (NENs), a category of malignancy that demonstrates wide clinical heterogeneity, posing major challenges in diagnosis and management. There have been significant advances in the field of NEN genomics, pathology, imaging, and treatment over the past five years. NENs are examples of rare tumours (although their incidence and prevalence are increasing) where international collaborative efforts have allowed the generation of high-level evidence to guide optimal patient-centred care. This issue presents both reviews and original papers to provide comprehensive state-of-the-art understanding of this fascinating disease. 2021-05-01T15:07:31Z 2021-05-01T15:07:31Z 2021 book ONIX_20210501_9783039437450_99 9783039437450 9783039437467 https://directory.doabooks.org/handle/20.500.12854/68354 eng application/octet-stream Attribution 4.0 International https://mdpi.com/books/pdfview/book/3363 https://mdpi.com/books/pdfview/book/3363 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-03943-746-7 10.3390/books978-3-03943-746-7 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783039437450 9783039437467 144 Basel, Switzerland open access
spellingShingle small bowel neuroendocrine tumours
pancreatic neuroendocrine tumours
liver metastases
midgut
meta-analysis
neuroendocrine tumors
carcinoid heart disease
carcinoid syndrome
somatostatin analogues
metastases
multidisciplinary
management
outcome
grading
staging
neuroendocrine neoplasms
chemotherapy
temozolomide
metronomic treatment
second-line
NOTCH
cancer-driven genes
mutational mechanism
germline mutations
small cell lung carcinoma
pancreatic NET
small bowel NET
medullary thyroid carcinoma
malignant castration-resistant prostatic cells
quality performance indicators
QPIs
cancer care
neuroendocrine tumour
NETs
modified Delphi
CommNETs
pancreatic neuroendocrine neoplasms
neuroendocrine tumor
long-term functional outcomes
pancreatectomy
diabetes mellitus
pancreatic exocrine insufficiency
body mass index
parenchyma-sparing surgery
neuroendocrine tumours
curative surgery
resection
follow-up
guidelines
relapse
recurrence
risk factor
mixed non-neuroendocrine neuroendocrine neoplasms
MiNENs
mixed adeno-neuroendocrine carcinoma
MANEC
2017 WHO classification
2019 WHO classification
thema EDItEUR::M Medicine and Nursing
Advances in Diagnosis and Therapy of Neuroendocrine Neoplasms
title Advances in Diagnosis and Therapy of Neuroendocrine Neoplasms
title_full Advances in Diagnosis and Therapy of Neuroendocrine Neoplasms
title_fullStr Advances in Diagnosis and Therapy of Neuroendocrine Neoplasms
title_full_unstemmed Advances in Diagnosis and Therapy of Neuroendocrine Neoplasms
title_short Advances in Diagnosis and Therapy of Neuroendocrine Neoplasms
title_sort advances in diagnosis and therapy of neuroendocrine neoplasms
topic small bowel neuroendocrine tumours
pancreatic neuroendocrine tumours
liver metastases
midgut
meta-analysis
neuroendocrine tumors
carcinoid heart disease
carcinoid syndrome
somatostatin analogues
metastases
multidisciplinary
management
outcome
grading
staging
neuroendocrine neoplasms
chemotherapy
temozolomide
metronomic treatment
second-line
NOTCH
cancer-driven genes
mutational mechanism
germline mutations
small cell lung carcinoma
pancreatic NET
small bowel NET
medullary thyroid carcinoma
malignant castration-resistant prostatic cells
quality performance indicators
QPIs
cancer care
neuroendocrine tumour
NETs
modified Delphi
CommNETs
pancreatic neuroendocrine neoplasms
neuroendocrine tumor
long-term functional outcomes
pancreatectomy
diabetes mellitus
pancreatic exocrine insufficiency
body mass index
parenchyma-sparing surgery
neuroendocrine tumours
curative surgery
resection
follow-up
guidelines
relapse
recurrence
risk factor
mixed non-neuroendocrine neuroendocrine neoplasms
MiNENs
mixed adeno-neuroendocrine carcinoma
MANEC
2017 WHO classification
2019 WHO classification
thema EDItEUR::M Medicine and Nursing
topic_facet small bowel neuroendocrine tumours
pancreatic neuroendocrine tumours
liver metastases
midgut
meta-analysis
neuroendocrine tumors
carcinoid heart disease
carcinoid syndrome
somatostatin analogues
metastases
multidisciplinary
management
outcome
grading
staging
neuroendocrine neoplasms
chemotherapy
temozolomide
metronomic treatment
second-line
NOTCH
cancer-driven genes
mutational mechanism
germline mutations
small cell lung carcinoma
pancreatic NET
small bowel NET
medullary thyroid carcinoma
malignant castration-resistant prostatic cells
quality performance indicators
QPIs
cancer care
neuroendocrine tumour
NETs
modified Delphi
CommNETs
pancreatic neuroendocrine neoplasms
neuroendocrine tumor
long-term functional outcomes
pancreatectomy
diabetes mellitus
pancreatic exocrine insufficiency
body mass index
parenchyma-sparing surgery
neuroendocrine tumours
curative surgery
resection
follow-up
guidelines
relapse
recurrence
risk factor
mixed non-neuroendocrine neuroendocrine neoplasms
MiNENs
mixed adeno-neuroendocrine carcinoma
MANEC
2017 WHO classification
2019 WHO classification
thema EDItEUR::M Medicine and Nursing
url ONIX_20210501_9783039437450_99